PharmaCyte Biotech Inc (NAS:PMCB)
$ 1.75 0.0399 (2.33%) Market Cap: 13.44 Mil Enterprise Value: -14.17 Mil PE Ratio: 2.65 PB Ratio: 0.28 GF Score: 40/100

PharmaCyte Biotech Inc Annual Shareholders Meeting Transcript

Dec 28, 2022 / 03:00PM GMT
Release Date Price: $2.87 (-1.37%)
Joshua Silverman
PharmaCyte Biotech, Inc. - Interim Chairman, Interim CEO

Good morning. Welcome to the 2022 annual meeting of stockholders of PharmaCyte Biotech Inc. I'm Joshua Silverman, Interim Chairman and Interim Chief Executive Officer, and it's my pleasure to welcome all of you. It is 10 AM Eastern, and in accordance with the notice of the meeting, I call to order the 2022 annual meeting of stockholders of PharmaCyte Biotech Inc. We have chosen to have this meeting virtually due to the continuing public health impact of COVID-19 to support the health and well-being of our stockholders, and in order to improve our stockholders access to this meeting.

It is our intention to conduct the meeting in accordance with this agenda. The agenda is currently shown on the screen available for review in the Meeting Materials section of the meeting website. There will be an opportunity for questions that are specific to the seven proposals [that are] presented. You will note that under Item 13 of the agenda an opportunity is provided at the end of the meeting for general questions and discussion specific

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot